Akums Drugs and Pharmaceuticals Limited (BOM:544222)
603.70
+2.25 (0.37%)
At close: Jun 19, 2026
BOM:544222 Market Cap
BOM:544222 has a market cap or net worth of 94.5 billion as of June 22, 2026. Its market cap has increased by 8.02% in one year.
Market Cap
94.50B
Enterprise Value
79.45B
Revenue
43.59B
Ranking
n/a
PE Ratio
37.03
Stock Price
603.70
Market Cap Chart
Since August 6, 2024, BOM:544222's market cap has decreased from 125.32B to 94.50B, a decrease of -24.59%. That is a compound annual growth rate of -14.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 92.58B | 33.37% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
| Aug 6, 2024 | 125.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |
| Granules India | 194.73B |
| Caplin Point Laboratories | 190.50B |
| Jubilant Pharmova | 152.96B |
| CORONA Remedies | 114.28B |
| Viyash Scientific | 111.10B |
| Procter & Gamble Health | 104.10B |